Average Co-Inventor Count = 4.77
ph-index = 26
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (289 from 292 patents)
2. Abbott Laboratories Corporation (43 from 4,179 patents)
3. Abbvie Inc. (4 from 822 patents)
4. Other (2 from 832,880 patents)
5. Pic Therapeutics, Inc. (2 from 5 patents)
6. Novartis Ag (1 from 3,923 patents)
7. Elmore Patent Law Group, P.c. (1 from 1 patent)
8. Enata Pharmacueticals, Inc. (1 from 1 patent)
9. Emata Pharmaceuticals, Inc (1 from 1 patent)
10. Enanta Pharmacueticals, Inc. (1 from 1 patent)
11. Abbvie Bahamas Limited (6 patents)
12. Abbvie Ireland Unlimited Company (0 patent)
342 patents:
1. 12509470 - Antiviral heterocyclic compounds
2. 12496282 - Hepatitis B antiviral agents
3. 12479854 - Spiropyrrolidine derived antiviral agents
4. 12459923 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
5. 12398147 - Macrocyclic spiropyrrolidine derived antiviral agents
6. 12384753 - 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
7. 12358921 - Antiviral heterocyclic compounds
8. 12297209 - Benzodiazepine derivatives as RSV inhibitors
9. 12281140 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
10. 12268694 - Combination pharmaceutical agents as RSV inhibitors
11. 12264159 - Functionalized heterocycles as antiviral agents
12. 12162857 - Antiviral compounds
13. 12157731 - EIF4E inhibitors and uses thereof
14. 12145941 - Heterocyclic antiviral agents
15. 12145942 - Spiropyrrolidine derived antiviral agents